tetano
Editor, Senior Moderator
Vaccine. 2017 Apr 4. pii: S0264-410X(17)30375-4. doi: 10.1016/j.vaccine.2017.03.058. [Epub ahead of print]
[h=1]Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.[/h] Hendin HE[SUP]1[/SUP], Pillet S[SUP]2[/SUP], Lara AN[SUP]3[/SUP], Wu CY[SUP]1[/SUP], Charland N[SUP]4[/SUP], Landry N[SUP]4[/SUP], Ward BJ[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]INTRODUCTION:[/h] The recent emergence of avian influenza strains has fuelled concern about pandemic preparedness since vaccines targeting these viruses are often poorly immunogenic. Weak antibody responses to vaccines have been seen across multiple platforms including plant-made VLPs. To better understand these differences, we compared the in vitro responses of human immune cells exposed to plant-made virus-like particle (VLP) vaccines targeting H1N1 (H1-VLP) and H5N1 (H5-VLP).
[h=4]METHODS:[/h] Peripheral blood mononuclear cells (PBMC) from healthy adults were stimulated ex vivo with 2-5?g/mL VLPs bearing the hemagglutinin (HA) of either H1N1 (A/California/7/2009) or H5N1 (A/Indonesia/5/05). VLP-immune cell interactions were characterized by confocal microscopy and flow cytometry 30min after stimulation with dialkylaminostyryl dye-labeled (DiD) VLP. Expression of CD69 and pro-inflammatory cytokines were used to assess innate immune activation 6h after stimulation.
[h=4]RESULTS:[/h] H1- and H5-VLPs rapidly associated with all subsets of human PBMC but exhibited unique binding preferences and frequencies. The H1-VLP bound to 88.7?1.6% of the CD19[SUP]+[/SUP] B cells compared to only 21.9?1.8% bound by the H5-VLP. At 6h in culture, CD69 expression on B cells was increased in response to H1-VLP but not H5-VLP (22.79?3.42% vs. 6.15?0.82% respectively: p<0.0001). Both VLPs were rapidly internalized by CD14[SUP]+[/SUP] monocytes resulting in the induction of pro-inflammatory cytokines (i.e.: IL-8, IL-1β, TNFα and IL-6). However, a higher concentration of the H5-VLP was required to induce a comparable response and the pattern of cytokine production differed between VLP vaccines.
[h=4]CONCLUSIONS:[/h] Plant-made VLP vaccines bearing H1 or H5 rapidly elicit immune activation and cytokine production in human PBMC. Differences in the VLP-immune cell interactions suggest that features of the HA proteins themselves, such as receptor specificity, influence innate immune responses. Although not generally considered for inactivated vaccines, the distribution and characteristics of influenza receptor(s) on the immune cells themselves may contribute to both the strength and pattern of the immune response generated.
Copyright ? 2017 Elsevier Ltd. All rights reserved.
[h=4]KEYWORDS:[/h] Influenza; Innate immunity; Plant-made vaccines; Virus-like particles
PMID: 28389100 DOI: 10.1016/j.vaccine.2017.03.058
[h=1]Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.[/h] Hendin HE[SUP]1[/SUP], Pillet S[SUP]2[/SUP], Lara AN[SUP]3[/SUP], Wu CY[SUP]1[/SUP], Charland N[SUP]4[/SUP], Landry N[SUP]4[/SUP], Ward BJ[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]INTRODUCTION:[/h] The recent emergence of avian influenza strains has fuelled concern about pandemic preparedness since vaccines targeting these viruses are often poorly immunogenic. Weak antibody responses to vaccines have been seen across multiple platforms including plant-made VLPs. To better understand these differences, we compared the in vitro responses of human immune cells exposed to plant-made virus-like particle (VLP) vaccines targeting H1N1 (H1-VLP) and H5N1 (H5-VLP).
[h=4]METHODS:[/h] Peripheral blood mononuclear cells (PBMC) from healthy adults were stimulated ex vivo with 2-5?g/mL VLPs bearing the hemagglutinin (HA) of either H1N1 (A/California/7/2009) or H5N1 (A/Indonesia/5/05). VLP-immune cell interactions were characterized by confocal microscopy and flow cytometry 30min after stimulation with dialkylaminostyryl dye-labeled (DiD) VLP. Expression of CD69 and pro-inflammatory cytokines were used to assess innate immune activation 6h after stimulation.
[h=4]RESULTS:[/h] H1- and H5-VLPs rapidly associated with all subsets of human PBMC but exhibited unique binding preferences and frequencies. The H1-VLP bound to 88.7?1.6% of the CD19[SUP]+[/SUP] B cells compared to only 21.9?1.8% bound by the H5-VLP. At 6h in culture, CD69 expression on B cells was increased in response to H1-VLP but not H5-VLP (22.79?3.42% vs. 6.15?0.82% respectively: p<0.0001). Both VLPs were rapidly internalized by CD14[SUP]+[/SUP] monocytes resulting in the induction of pro-inflammatory cytokines (i.e.: IL-8, IL-1β, TNFα and IL-6). However, a higher concentration of the H5-VLP was required to induce a comparable response and the pattern of cytokine production differed between VLP vaccines.
[h=4]CONCLUSIONS:[/h] Plant-made VLP vaccines bearing H1 or H5 rapidly elicit immune activation and cytokine production in human PBMC. Differences in the VLP-immune cell interactions suggest that features of the HA proteins themselves, such as receptor specificity, influence innate immune responses. Although not generally considered for inactivated vaccines, the distribution and characteristics of influenza receptor(s) on the immune cells themselves may contribute to both the strength and pattern of the immune response generated.
Copyright ? 2017 Elsevier Ltd. All rights reserved.
[h=4]KEYWORDS:[/h] Influenza; Innate immunity; Plant-made vaccines; Virus-like particles
PMID: 28389100 DOI: 10.1016/j.vaccine.2017.03.058